These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8704622)

  • 1. [The effect of the subchronic administration of calcium-channel blockers on CNS excitability].
    Kozlovskiĭ VL; Mosin AE; Ivakina LV
    Eksp Klin Farmakol; 1996; 59(1):14-6. PubMed ID: 8704622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 1997; 60(5):19-22. PubMed ID: 9483399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of calcium channel blocker nifedipine on anxiety and seizure manifestations of abstinence syndrome in rats after withdrawal of long-term diazepam administration].
    Garibova TL; Val'dman EA; Voronina TA; Kraĭneva VA
    Biull Eksp Biol Med; 1998 May; 125(5):538-40. PubMed ID: 9644553
    [No Abstract]   [Full Text] [Related]  

  • 4. [A model for the study of CNS excitability (the potentials for research on the antiepileptic activity of preparations in a chronic experiment)].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 1994; 57(3):25-6. PubMed ID: 7914113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of calcium channel blockers on anxiety evoked by amputation of the vibrissae in rats].
    Kozlovskiĭ VL; Mosin AE; Ivakina LV
    Eksp Klin Farmakol; 1997; 60(1):10-2. PubMed ID: 9162271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuromediator mechanisms of the action of korazol].
    Kaluev AV; Filonenko MA; Gromov LA
    Fiziol Zh (1994); 2000; 46(4):80-7. PubMed ID: 10997305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of calcium channel blockers on the effects of anxiogenic preparations].
    Kozlovskiĭ VL
    Patol Fiziol Eksp Ter; 2000; (3):3-4. PubMed ID: 10983469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice].
    Golovenko NIa; Zin'kovskii VG
    Biull Eksp Biol Med; 1976 Sep; 82(9):1078-81. PubMed ID: 11012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of calcium channel blockers on the central action of clonidine.
    Czarnecka E; Tymczyszyn W
    Pol J Pharmacol; 1994; 46(3):125-31. PubMed ID: 8000443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium channel blockers as antidepressants--a property of the class or of the individual preparation?].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1994; 57(1):17-20. PubMed ID: 8142855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intracerebral route of kynurenine administration is one of the reasons for the resistance of kynurenine-induced seizures to diazepam].
    Lapin IP
    Eksp Klin Farmakol; 1998; 61(3):22-4. PubMed ID: 9690070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats].
    Kozlovskiĭ VL; Prakh'e IV; Kenunen OG
    Eksp Klin Farmakol; 1996; 59(3):12-5. PubMed ID: 8974575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine inhibits picrotoxin-induced seizure activity: further evidence on the involvement of L-type calcium channel blockers in epilepsy.
    Otoom S; Hasan Z
    Fundam Clin Pharmacol; 2006 Apr; 20(2):115-9. PubMed ID: 16573711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The polymorphism of the pharmacological effects of calcium channel blockers].
    Ivanova TM; Podosinovikova NP; Dolgo-Saburov VB; Predtechenskiĭ MB; Stepanova NA
    Farmakol Toksikol; 1990; 53(2):34-6. PubMed ID: 2369951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diazepam withdrawal syndrome by nifedipine-behavioural and neurochemical studies.
    El Ganouni S; Hanoun N; Boni C; Tazi A; Hakkou F; Hamon M
    Pharmacol Biochem Behav; 2004 Oct; 79(2):269-77. PubMed ID: 15501302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of voltage dependent calcium channels and cholinergic receptors in the convulsant action of BAY k-8644.
    Wielosz M; Młynarczyk M; Kleinrok Z
    Pol J Pharmacol; 1997; 49(5):369-71. PubMed ID: 9566038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.